Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.
about
Nano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesFundamentals of aerosol therapy in critical careImmunogenetics of type 1 diabetes mellitusPharmaceutical particle engineering via spray drying.Inhaled insulin: overview of a novel route of insulin administration.STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update.Recent advances in treatment of youth with Type 1 diabetes: better care through technology.Inhaled insulin: a novel route for insulin delivery.Insulin analogues and other developments in insulin therapy for diabetes.Inhaled insulin for the treatment of diabetes: projects and devices.Alternative routes of insulin delivery.Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development.Insulin treatment in children and adolescents.Diabetes mellitus and the pediatric anesthetist.Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetesInhaled human insulin (Exubera): clinical profile and patient considerations.New strategies in insulin treatment: analogues and noninvasive routes of administration.Inhaled insulin: Exubera.Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung.Dry powder inhalers for pulmonary drug delivery.Commercial challenges of protein drug delivery.Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.Noninvasive delivery technologies: respiratory delivery of vaccines.Diabetes therapy trials with inhaled insulin.Inhaled insulin for controlling blood glucose in patients with diabetesInhaled insulin delivery--where are we now?Inhaled insulin (Exubera): Combining efficacy and convenience.First approved inhaled insulin therapy for diabetes mellitus.Inhaled insulins.Insulin structure and function.Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.Recent challenges in insulin delivery systems: a review.Rheumatic involvement of the cleft mitral valve.Nanocarriers for pulmonary administration of peptides and therapeutic proteins.In pursuit of excellence in diabetes care: trends in insulin delivery.Inhaled human insulin (Exubera(®)): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus.Influence of absorption promoters on pulmonary insulin bioactivity.Cell-based multiscale computational modeling of small molecule absorption and retention in the lungs.
P2860
Q26786162-E6F2EC5B-8C83-4F5C-AA8F-137773E23DF3Q28068836-48279437-0B43-4963-BA58-2D252D71F19DQ28087365-E0554F79-C1BD-4B79-8F73-8AD632BCA86BQ30496354-104B1BDF-E87C-4291-A0C8-E962AD0ADD52Q33715395-FF48D0C5-DE62-4B15-96AA-48FB249EE955Q33904977-D3B37CE1-15DE-4E82-BCA5-3A312872C278Q34433909-758A5087-37AC-42C0-8120-2AB153D15835Q34434731-5CBEF42E-8675-443E-84AD-90B2C7E4DBC3Q34628686-04BD6A09-BDBE-430F-BAF2-49BC71C7A6D2Q35164710-8C58073F-F78E-4745-9860-41CC9BE77FA2Q35183764-F2745B60-8C2C-46F7-86DF-33B3C642F28CQ35591065-3526FC31-BC8B-4E44-88A5-ACAD770FCEEDQ35756163-9CDC78A4-8DDD-495A-8ABD-70A88542DFA8Q35799765-8784680D-BC56-4BF7-8F70-16EFF0CC26FDQ35872125-D2324FEC-F1E6-4960-816D-B9DAEB9571B6Q35876380-4044F213-B640-4F7F-B3B2-FFCD27A776D7Q36013146-96F89C3F-9EF4-4F1D-9005-6177889F424AQ36089348-25F4E286-17AB-42AB-A9EF-D3F45B374CEBQ36096727-703492F3-8C19-4D33-8EE6-6C790DAA0BFFQ36245839-79E639BF-A011-4CD9-90CE-075A73728079Q36316621-2C703372-C8CC-481B-B2A3-1967DF7DE86EQ36316655-CDE2828D-3654-49B8-8355-F02EDCF49D48Q36330292-7FC11003-9283-4DA0-AC4E-B97E6998DAE0Q36349694-F7FEBA75-714B-4F68-AFAD-F7B2C8B75510Q36512554-23293941-0EBE-47D2-BB43-F3D2C71A1BCFQ36596878-F035EA78-9010-4FB3-B5C0-A29853754EA7Q36616573-4319E419-5874-49AD-B8C5-275184E2CC7EQ36679610-4AB8D41B-F45B-4BC5-B8A6-DFC838EAB2ADQ36690218-07458079-0937-4C7B-A1E8-84BDFF3C4C1DQ36754100-892ADC3E-AB5B-4F66-9ADB-9277228AB3ABQ36780901-851A9152-D006-45AD-8926-B43C5C11496EQ36856384-463BED2D-0BE2-477E-96BC-5EAC6BF2E204Q36889912-C4AEF389-4206-4BFC-B05E-CB26CC6B570BQ37472722-90A473C5-2439-4414-840D-D2ABE93940FFQ37672925-F8F798DA-E6C2-47B9-9F20-485D4273A638Q37823598-A72E0DCD-F81E-49A8-A55F-3A42DAB5D8DDQ39572372-7E31DFBB-E011-44B5-8F3C-CF4FD9A133E8Q40138501-5426063D-CECA-425C-977F-2663D39A4572Q41998445-49E77590-814D-47DB-905D-B304FE093525Q42117539-70D2BCAA-23D8-4CE1-9F7B-614BA41D9628
P2860
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacy of inhaled human insu ...... omised proof-of-concept study.
@ast
Efficacy of inhaled human insu ...... omised proof-of-concept study.
@en
type
label
Efficacy of inhaled human insu ...... omised proof-of-concept study.
@ast
Efficacy of inhaled human insu ...... omised proof-of-concept study.
@en
prefLabel
Efficacy of inhaled human insu ...... omised proof-of-concept study.
@ast
Efficacy of inhaled human insu ...... omised proof-of-concept study.
@en
P2093
P1433
P1476
Efficacy of inhaled human insu ...... omised proof-of-concept study.
@en
P2093
C C Balagtas
I A Kourides
J S Skyler
R A Gelfand
W H Landschulz
W T Cefalu
P304
P356
10.1016/S0140-6736(00)03638-2
P407
P577
2001-02-01T00:00:00Z